Intravenous immunoglobulin
Intravenous immunoglobulin-associated hemolysis: risk factors, challenges, and solutions
... with intravenous immunoglobulin (IVIG) administration has recently been identified as a major problem requiring special attention, after increased incidence has been documented by US FDA since ...
11
Hemolysis induced cross matching difficulty with intravenous immunoglobulin: a case report
... Background: Intravenous immunoglobulin is one of the most common modalities of treatment for Guillain – Barré ...failure. Intravenous immunoglobulin at ...in intravenous ...
6
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
... IVIG: Intravenous immunoglobulin; MAC: Membrane attack complex; MBD: Microtubule binding domains; MCI: Mild cognitive impairment; NFTs: Neurofibrillary tangles; sIVIG: Target-specific IVIG; RAGE: Receptor ...
10
Intravenous Immunoglobulin Therapy for Refractory Recurrent Pericarditis
... human intravenous immunoglobulin, immunosuppressive drugs, and biologi- cal agents have been ...g/kg) intravenous immunoglobulin until resolution of the ...
8
Criteria for the clinical use of intravenous immunoglobulin in Australia
... accessing intravenous immunoglobulin funded under the National Blood ...of intravenous immunoglobulin in Australia (the Criteria) have not been subject to a systematic review and should not be ...
286
Low dose Methotrexate Therapy for Intravenous Immunoglobulin resistant Kawasaki Disease
... Purpose: The aim of this study was to evaluate the efficacy of low-dose oral methotrexate (MTX) as a treatment for patients with Kawasaki disease (KD) which was resistant to intravenous immunoglobulin ...
5
Parameters to Guide Rescue Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
... an intravenous immunoglobulin (IVIG) therapy resistance is one of the most important factors for CAL development during the acute phase of Kawasaki disease ...
8
Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
... Abstract: Influenza viruses A/H1N1, A/H3N2, and B are known seasonal viruses that undergo annual mutation. Intravenous immunoglobulin (IVIG) contains anti-seasonal influenza virus globulins. Although the ...
8
Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
... with intravenous immunoglobulin therapy aims to reduce the incidence of infections; however, as serum IgG approaches its trough during the third and fourth week after infusion, we hypothesized that the rate ...
5
Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
... with intravenous immunoglobulin (IVIG) has been associated with CAL formation [21], and an increase in eosinophils after IVIG treatment has been inversely correlated with failure rate of IVIG treatment in ...
6
Intravenous Immunoglobulin Therapy in Myocarditis
... Myocarditis is an inflammatory disease of the myocardium with lymphocyte infiltration and myocyte necrosis leading to a wide range of clinical presentations including heart failure, arrhythmia, and cardiogenic shock. ...
14
Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis
... Background: Postpolio syndrome (PPS) is characterized by progressive disabilities that develop decades after prior paralytic poliomyelitis. Because chronic inflammation may be the process underlying the development of ...
9
Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa
... with intravenous immunoglobulin (IVIG) completing six cycles (2 g/kg in each cycle), while maintaining treatment with prednisolone and azathioprine (150 ...
5
Intravenous Immunoglobulin in the Treatment of Acute Disseminated Encephalomyelitis
... Acute Disseminated Encephalomyelitis (ADEM) is a rare immune-mediated condition predominantly affecting children. MRI scans are required to confirm the diagnosis and to distinguish it from Multiple Sclerosis in the few ...
5
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
... Although intravenous immunoglobulin (IVIG) combined with aspirin were commonly adopted as the most important therapy protocol which could effectively decrease the incidence of coronary artery lesions ...
9
Varicella-Specific Immunoglobulin G Titers in Commercial Intravenous Immunoglobulin Preparations
... specific immunoglobulin is recommended for treatment of nonim- mune, exposed, high-risk patients with varicella-specific immunoglob- ...of intravenous immunoglobulin (IVIg) for such prophylaxis on the ...
7
Treatment of Kimura Disease With Intravenous Immunoglobulin
... Kimura disease is an uncommon chronic inflammatory condition of unknown etiology and is characterized by painless subcutaneous nod- ules, usually affecting the head and neck, eosinophilia, and markedly elevated ...
5
High-dose of intravenous immunoglobulin modulates immune tolerance in premature infants
... of preterm infants [6]. Intravenous immunoglobulin (IVIG) is a polyclonal immunoglobulin G preparation with widely immunomodulatory properties. IVIG can increase the number and the suppressive ...
7
Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
... is intravenous administration of IgM-enriched immunoglobulins since this could potentially decrease the severity of inflamma- ...with intravenous immunoglobulin therapy in immune-compromised patients ...
8
Acute Encephalopathy Associated with Intravenous Immunoglobulin Therapy
... high-dose intravenous immuno- globulin therapy. Within 48 hours of intravenous im- munoglobulin infusion, the patient complains of se- vere headache, fever, vomiting, nuchal rigidity, drowsiness, and ...of ...
5